2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Does the magnitude of improvement of UPDRS III at the preoperative L-dopa test predict the degree of medication decrease one year after subthalamic nucleus Deep Brain Stimulation?

A. Fredricks, G-M. Hariz, J. Linder, L. Eriksson, L. Forsgren, M. Hariz, P. Blomstedt (Umea, Sweden)
Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients

J. Kenna, S. Mcgregor, M. Horne, A. Tay, S. Ghosh, F. Mastaglia, A. Jefferson, A. Gorecki, M. Bakeberg, S. Walters, R. Anderton (Perth, Australia)
Does Transcranial Direct Current Simulation Improve Motor Functions in Patients with Parkinson’s disease?

E. Bahbah, M. Morsi, M. Aziz, A. Hassanen, A. Ali, M. Abdelmongy, M. Sinokrot, A. Negida, A. Shalash (Damietta, Egypt)
Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia

D. Martino, Y. Jasaui, J. Sarna, S. Furtado, S. Patten, T. Pringsheim (Calgary, AB, Canada)
Dopamine agonist withdrawal syndrome in Sardinian patients affected by Parkinson’s disease

P. Paolo, R. Pau, G. Orofino, T. Ercoli, F. Marrosu, G. Defazio (Monserrato, Italy)
Dopamine dysregulation syndrome and levodopa-induced dyskinesias in patients with Parkinson’s disease on the background of deep stimulation of the subthalamic nucleus

S. Omarova, N. Fedorova, A. Tomskiy, A. Gamaleya, E. Bril (Moscow, Russian Federation)
Dopamine receptor variants alter outcomes with levodopa in early-stage Parkinson’s disease

D. Fischer, P. Auinger, J. Goudreau, A. Cole-Strauss, K. Kieburtz, J. Elm, M. Hacker, P. Charles, J. Lipton, B. Pickut, C. Sortwell (Grand Rapids, MI, USA)
Dopamine substitution increases connectivity between premotor and motor areas in Parkinson’s disease – a DCM-Study

P. Loehrer, V. Seeger, I. Weber, C. Oehrn, H. Dafsari, M. Tittgemeyer, L. Timmermann (Marburg, Germany)
Dopaminergic imaging in patients with basal ganglia calcification presenting with parkinsonism

A. Planas-Ballvé, N. Caballol, M. Balagué, E. Peral, L. Cano, X. Cardona, L. Vila, A. ávila (Sant Joan Despí, Spain)
Dopaminergic Neuroregeneration in the Diencephalon of 6-OHDA-Lesioned Adult Zebrafish-Based Parkinson’s Disease Model

Y. Vijayanathan, SM. Lim, MP. Tan, FT. Lim, AB. Abdul Majeed, K. Ramasamy (Kuala Lumpur, Malaysia)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z